Medullary Thyroid Carcinoma Mutation Detection Test sale cost 3510 AED
Cancer Targeted Gene Panel Colon Colorectal Test sale cost 2970 AED Cancer Targeted Gene Panel Colon Colorectal Test Cost 3,960 د.إ Original price was: 3,960 د.إ.2,970 د.إCurrent price is: 2,970 د.إ.
LPL Expert Panel 2 Test sale cost 3280 AED LPL Expert Panel 2 Test Cost 3,640 د.إ Original price was: 3,640 د.إ.3,280 د.إCurrent price is: 3,280 د.إ.
Sale!

Medullary Thyroid Carcinoma Mutation Detection Test Cost

Original price was: 3,900 د.إ.Current price is: 3,510 د.إ.

-10%

Medullary Thyroid Carcinoma (MTC) is a rare type of thyroid cancer that arises from the parafollicular cells (C cells) of the thyroid gland, which produce the hormone calcitonin. Early detection and treatment of MTC are crucial for improving patient outcomes. One of the key methods for detecting MTC involves identifying genetic mutations associated with the disease. The Medullary Thyroid Carcinoma Mutation Detection Test is a specialized diagnostic tool designed to identify specific genetic mutations in the RET proto-oncogene, which are known to increase the risk of developing MTC. This test is particularly important for individuals with a family history of MTC or for those diagnosed with thyroid nodules, as it helps in the early diagnosis and management of the condition.

Performed at DNA Labs UAE, the Medullary Thyroid Carcinoma Mutation Detection Test is conducted with state-of-the-art genetic testing technologies to ensure high sensitivity and specificity. The test cost is set at 3510 AED, reflecting the advanced nature of the technology and the expertise required to accurately interpret the results. By identifying the presence of mutations associated with MTC, this test plays a pivotal role in personalized patient care, allowing for tailored treatment strategies and improved surveillance for affected individuals and their families.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

MEDULLARY THYROID CARCINOMA MUTATION DETECTION Test

Test Cost: AED 3510.0

Symptoms, Diagnosis, and Test Details

The MEDULLARY THYROID CARCINOMA MUTATION DETECTION Test is a diagnostic test used to identify specific genetic mutations associated with medullary thyroid carcinoma (MTC). MTC is a rare type of thyroid cancer that originates from the C-cells of the thyroid gland.

The test analyzes a sample of the patient’s DNA, typically obtained from a blood or tissue sample. It specifically looks for mutations in the RET gene, which is known to be involved in the development of MTC. RET gene mutations are found in about 95% of hereditary cases of MTC and in about 45% of sporadic (non-hereditary) cases.

Detecting these mutations is important for several reasons. First, it helps confirm the diagnosis of MTC, as the presence of RET gene mutations is highly indicative of this type of cancer. Second, it can help determine the hereditary nature of MTC, as certain RET mutations are associated with familial cases of the disease. Finally, identifying specific mutations can guide treatment decisions, as some mutations may respond better to targeted therapies.

Test Components and Sample Condition

  • Components: MEDULLARY THYROID CARCINOMA MUTATION DETECTION Test
  • Price: AED 3510.0
  • Sample Condition: 4 mL (2 mL min.) whole blood in 1 Lavender top (EDTA) tube. Ship refrigerated. DO NOT FREEZE.
  • Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.

Report Delivery and Test Type

  • Report Delivery: Sample Daily by 11 am; Report 10 Working days
  • Method: PCR
  • Test Type: Cancer

Doctor and Test Department

  • Doctor: Oncologist
  • Test Department: MOLECULAR DIAGNOSTICS

Pre Test Information

Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.

Important Notes

  • This test specifically detects mutations associated with MTC and is not used to diagnose other types of thyroid cancer or non-cancerous thyroid conditions.
  • The test is not typically performed as a routine screening test, but rather in individuals with suspected or confirmed MTC or a family history of the disease.
Test Name MEDULLARY THYROID CARCINOMA MUTATION DETECTION Test
Components
Price 3510.0 AED
Sample Condition 4 mL (2 mL min.) whole blood in 1 Lavender top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.
Report Delivery Sample Dailyby 11 am;Report 10 Working days
Method PCR
Test type Cancer
Doctor Oncologist
Test Department: MOLECULAR DIAGNOSTICS
Pre Test Information Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.
Test Details

The MEDULLARY THYROID CARCINOMA MUTATION DETECTION Test is a diagnostic test used to identify specific genetic mutations associated with medullary thyroid carcinoma (MTC). MTC is a rare type of thyroid cancer that originates from the C-cells of the thyroid gland.

The test analyzes a sample of the patient’s DNA, typically obtained from a blood or tissue sample. It specifically looks for mutations in the RET gene, which is known to be involved in the development of MTC. RET gene mutations are found in about 95% of hereditary cases of MTC and in about 45% of sporadic (non-hereditary) cases.

Detecting these mutations is important for several reasons. First, it helps confirm the diagnosis of MTC, as the presence of RET gene mutations is highly indicative of this type of cancer. Second, it can help determine the hereditary nature of MTC, as certain RET mutations are associated with familial cases of the disease. Finally, identifying specific mutations can guide treatment decisions, as some mutations may respond better to targeted therapies.

The MEDULLARY THYROID CARCINOMA MUTATION DETECTION Test is typically ordered by a healthcare provider specializing in endocrinology or oncology. The test results are usually reported as either positive (indicating the presence of a mutation) or negative (indicating the absence of a mutation). In some cases, the test may also provide information about the specific type of mutation detected.

It is important to note that this test specifically detects mutations associated with MTC and is not used to diagnose other types of thyroid cancer or non-cancerous thyroid conditions. Additionally, the test is not typically performed as a routine screening test, but rather in individuals with suspected or confirmed MTC or a family history of the disease.

SKU: TEST-4725 Category:

Related products